A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy

Abstract

With a VTDR prevalence similar to that in the U.S., the RETeval device will identify about 75% of the population as not having VTDR with 99% accuracy. The device is simple to use, does not require pupil dilation, and has a short testing time.